RYZODEG 70/30 FDA approval date

The FDA approved RYZODEG 70/30 on 25 Sep 2015.

FDA approval date
25 Sep 2015

Drug identity has not yet been verified against registry records

Also recorded as INSULIN ASPART; INSULIN DEGLUDEC

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2015-09-25DayRYZODEG 70/30FDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "BLA203313", "applicant_as_listed_by_fda": "NOVO", "brand_names": ["RYZODEG 70/30"], "active_ingredients": ["INSULIN ASPART", "INSULIN DEGLUDEC"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150925", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026